Atara Biotherapeutics stock price
아타라 바이오테라퓨틱스NASDAQ:ATRA · Nasdaq · Healthcare$9.48+12.06%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Atara Biotherapeutics last closed at $9.48 (+12.06%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -8.5×. Its overall grade ranks 255 of 739 stocks in Healthcare.
About this company
Atara Biotherapeutics last closed at $9.48 (+12.06%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 255/739
Valuation grade A+
Related stocks
- Fresenius BioSolutionsCustomer
ATA188 개발/상업화 관련 공급·제조 파트너로 거론된 바 있음
- AmgenCompetitor
세포·면역질환 및 희귀질환 바이오의약품 분야의 대형 경쟁사
- Bristol Myers SquibbCompetitor
세포치료·면역항암제 분야에서 경쟁하는 대형 제약사
About Atara Biotherapeutics
- What technical signals does Atara Biotherapeutics (ATRA) have?
- Atara Biotherapeutics current technical signals: no active technical signal.
- Is Atara Biotherapeutics a cup-and-handle pattern?
- No. Atara Biotherapeutics has no valid Cup signal right now.
- What published figures are available for Atara Biotherapeutics?
- Market cap: $68.35M. Trailing 12 months PER: -8.5×. Latest quarter PBR: -3.85×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Atara Biotherapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy